BioCentury
ARTICLE | Company News

Savient slides on inability to sell

October 26, 2010 12:38 AM UTC

Savient Pharmaceuticals Inc. (NASDAQ:SVNT) fell $9.63 (44%) to $12.07 on Monday after announcing it was unable to sell itself at this time. In May, Savient announced plans to sell the company followin...